TG6002 oncolytic vaccinia virus and chemotherapy synergy: a promising strategy for pancreatic ductal adenocarcinoma

Pancreatic ductal adenocarcinoma (PDAC) is a highly malignant cancer characterized by poor prognosis and limited treatment options, often associated with significant toxicity. Recently, we described TG6002, an oncolytic vaccinia virus (VACV) engineered for tumor-selective replication through the del...

Volledige beschrijving

Bibliografische gegevens

Hoofdauteurs:	Johann Foloppe, Isabelle Farine, Christelle Pichon, Juliette Kempf, Julie Hortelano, Baptiste Moreau, Sandrine Cochin, Armelle Takeda, Patrick Pessaux, Philippe Erbs
Formaat:	Artigo
Taal:	Inglês
Gepubliceerd in:	Frontiers Media S.A. 2025-09-01
Reeks:	Frontiers in Microbiology
Onderwerpen:	pancreatic ductal adenocarcinoma oncolytic vaccinia virus TG6002 combination chemotherapy patient-derived tumor models
Online toegang:	https://www.frontiersin.org/articles/10.3389/fmicb.2025.1656984/full
Tags:	Voeg label toe Geen labels, Wees de eerste die dit record labelt!